These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 18641098)

  • 1. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
    Choudhury A; Chung I; Blann AD; Lip GYH
    Chest; 2007 Mar; 131(3):809-815. PubMed ID: 17356097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
    Choudhury A; Chung I; Blann AD; Lip GY
    J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation.
    Tarnowski D; Poitz DM; Plichta L; Heidrich FM; Wiedemann S; Ruf T; Mierke J; Löhn T; Jellinghaus S; Strasser RH; Ibrahim K; Pfluecke C
    Platelets; 2018 Jan; 29(1):41-47. PubMed ID: 28287031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
    Lim HS; Blann AD; Lip GY
    Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction.
    Blann AD; Choudhury A; Freestone B; Patel J; Lip GY
    Int J Cardiol; 2008 Jun; 127(1):135-7. PubMed ID: 17555832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2 diabetes.
    Neubauer H; Setiadi P; Günesdogan B; Pinto A; Börgel J; Mügge A
    Diabet Med; 2010 Apr; 27(4):384-90. PubMed ID: 20536508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
    Chung I; Choudhury A; Patel J; Lip GY
    J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
    Choudhury A; Freestone B; Patel J; Lip GY
    Chest; 2007 Dec; 132(6):1913-9. PubMed ID: 18079224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of CD40/CD40L system in rheumatic mitral stenosis with or without atrial fibrillation.
    Azzam H; Abousamra NK; Wafa AA; Hafez MM; El-Gilany AH
    Platelets; 2013; 24(7):516-20. PubMed ID: 22992131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
    Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
    Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
    Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
    Blann AD; Tan KT; Tayebjee MH; Davagnanam I; Moss M; Lip GY
    Thromb Haemost; 2005 Mar; 93(3):578-83. PubMed ID: 15735813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.
    Lip GY; Patel JV; Hughes E; Hart RG
    Stroke; 2007 Apr; 38(4):1229-37. PubMed ID: 17332453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
    Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions.
    Riondino S; Martini F; La Farina F; Spila A; Guadagni F; Ferroni P
    Clin Biochem; 2010 May; 43(7-8):666-70. PubMed ID: 20060822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
    Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
    Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.
    Lim HS; Willoughby SR; Schultz C; Gan C; Alasady M; Lau DH; Leong DP; Brooks AG; Young GD; Kistler PM; Kalman JM; Worthley MI; Sanders P
    J Am Coll Cardiol; 2013 Feb; 61(8):852-60. PubMed ID: 23333141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced platelet responsiveness due to chilling and its relation to CD40 ligand level and platelet-leukocyte aggregate formation.
    Ayukawa O; Nakamura K; Kariyazono H; Ikeda R; Arima J; Shinkawa T; Iwase H; Sakata R; Yamada K
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):176-84. PubMed ID: 19300046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.